Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
An economic evaluation was undertaken to assess the potential for introducing rotavirus vaccine into Indonesia's National Immunization Program. For a projected birth cohort of 4.2 million children was followed until 5 years of age, a routine rotavirus vaccination programme could potentially avert 488,547 cases of diarrhoea treated in outpatient hospital facilities, 176,375 hospitalizations, and 8148 deaths. Assuming a cost of US$ 14 per vaccine course, the incremental cost-effectiveness ratio would equal US$ 120.46 per disability adjusted life years averted, making routine vaccination highly cost-effective given Indonesia's Gross National Income per capita of US$ 1560. At a cost per vaccine course of US$ 3.79 (societal perspective) or US$ 2.70 (health-care system perspective), routine rotavirus vaccination could be potentially cost-saving in Indonesia.
Wilopo
Siswanto Agus
SA
Centre of Reproductive Health, Department of Public Health, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia. sawilopo@yahoo.com
Kilgore
Paul
P
Kosen
Soewarta
S
Soenarto
Yati
Y
Aminah
Sri
S
Cahyono
Anton
A
Ulfa
Maria
M
Tholib
Abu
A
D002675:Child, Preschool; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003967:Diarrhea / Q000517:prevention & control*; D017048:Health Care Costs; D006760:Hospitalization / Q000191:economics; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D015994:Incidence; D007214:Indonesia; D007223:Infant; D018803:Models, Economic; D012400:Rotavirus Infections / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000191:economics*
D022243:Rotavirus Vaccines